NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC) - Pembrolizumab experimental arm (EA) primary results Meeting Abstract
| Authors: | Rahma, O. E.; Yothers, G.; Hong, T. S.; Russell, M. M.; You, N. Y.; Parker, W.; Jacobs, S. A.; Colangelo, L. H.; Lucas, P. C.; Gollub, M. J.; Hall, W. A.; Kachnic, L. A.; Vijayvergia, N.; Wolmark, N.; George, T. J. |
| Abstract Title: | NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC) - Pembrolizumab experimental arm (EA) primary results |
| Meeting Title: | 2021 Gastrointestinal Cancers Symposium (ASCO GI) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 15-17 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-01-20 |
| Language: | English |
| ACCESSION: | WOS:000636712800064 |
| DOI: | 10.1200/JCO.2021.39.3_suppl.8 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 8 -- Source: Wos |
